Related Experiment Video
Updated: May 28, 2026

A Hydrogel Construct and Fibrin-based Glue Approach to Deliver Therapeutics in a Murine Myocardial Infarction Model.
Published on: June 14, 2015
Angiogenic therapy for cardiac repair based on protein delivery systems
F R Formiga1, E Tamayo, T Simón-Yarza
1Department of Pharmacy and Pharmaceutical Technology, School of Pharmacy, University of Navarra, Pamplona, Spain.
Insights
Growth factors show promise for cardiac repair in ischemic heart disease patients ineligible for surgery. Research explores their role in blood vessel formation and therapeutic delivery for heart regeneration.
Area of Science:
- Cardiovascular Medicine
- Regenerative Medicine
- Molecular Biology
Background:
- Cardiovascular diseases are a leading cause of death globally, with ischemic heart disease posing a significant challenge.
- Current treatments like angioplasty and bypass surgery are not suitable for all patients.
- Gene, cell, and protein therapies are emerging as novel treatment strategies.
Purpose of the Study:
- To review potential growth factors for cardiac repair.
- To examine the role of growth factors in angiogenesis and their therapeutic implications.
- To discuss challenges and strategies for growth factor delivery in cardiac regeneration.
Main Methods:
- Literature review focusing on growth factors for cardiac repair.
- Analysis of the angiogenic process and therapeutic potential of growth factors.
- Examination of growth factor delivery aspects: protein stability, dosage, routes, and safety.
Main Results:
- Growth factors play a crucial role in promoting angiogenesis, essential for repairing damaged heart tissue.
- Various growth factors are being investigated for their efficacy in cardiac regeneration.
- Controlled delivery systems are being developed to optimize protein stability, dosage, and safety.
Conclusions:
- Growth factor therapy represents a promising avenue for treating ischemic heart disease, particularly for patients unsuitable for conventional procedures.
- Optimizing growth factor delivery is critical for successful cardiac regeneration.
- Further research into novel protein delivery platforms is essential for advancing cardiac repair therapies.
Abstract:
Cardiovascular diseases remain the first cause of morbidity and mortality in the developed countries and are a major problem not only in the western nations but also in developing countries. Current standard approaches for treating patients with ischemic heart disease include angioplasty or bypass surgery. However, a large number of patients cannot be treated using these procedures. Novel curative approaches under investigation include gene, cell, and protein therapy. This review focuses on potential growth factors for cardiac repair. The role of these growth factors in the angiogenic process and the therapeutic implications are reviewed. Issues including aspects of growth factor delivery are presented in relation to protein stability, dosage, routes, and safety matters. Finally, different approaches for controlled growth factor delivery are discussed as novel protein delivery platforms for cardiac regeneration.
Related Concept Videos
Mechanism of Angiogenesis
Regulation of Angiogenesis and Blood Supply

